Febrifugine dihydrochloride

CAS No. 32434-42-7

Febrifugine dihydrochloride ( Atensil; Febrifugine dihydrochloride; ISF-2123; Pildralazine dihydrochloride; Propyldazine hydrochloride )

Catalog No. M29036 CAS No. 32434-42-7

Febrifugine dihydrochloride is a biochemical with therapeutic activity regarding malaria, cancer, fibrosis and inflammatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 127 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Febrifugine dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Febrifugine dihydrochloride is a biochemical with therapeutic activity regarding malaria, cancer, fibrosis and inflammatory diseases.
  • Description
    Febrifugine dihydrochloride is a biochemical with therapeutic activity regarding malaria, cancer, fibrosis and inflammatory diseases.
  • Synonyms
    Atensil; Febrifugine dihydrochloride; ISF-2123; Pildralazine dihydrochloride; Propyldazine hydrochloride
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32434-42-7
  • Formula Weight
    374.3
  • Molecular Formula
    C16H21Cl2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.Cl.O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2ccccc2c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Oxamniquine

    Oxamniquine is a potent agent for the treatment of schistosomiasis.

  • Artefenomel

    Artefenomel (OZ439) is a novel, next-generation antimalarial ozonide that demonstrates high potentcy against P. falciparum in vitro and P. berghei in vivo (K1/NF54, IC50=2.0/3.2 nM).

  • Ganaplacide

    Ganaplacide (KAF156, GNF-156)is a novel antimalarial clinical candidate that shows blood schizonticidal activity with IC50 of 6-17.4 nM against P falciparum drug-sensitive and drug-resistant strains.